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Background: The HAPPY study is a large prospective longitudinal cohort study in which pregnant women
(N ≈ 2,500) are followed during the entire pregnancy and the whole first year postpartum. The study collects a
substantial amount of psychological and physiological data investigating all kinds of determinants that might
interfere with general well-being during pregnancy and postpartum, with special attention to the effect of maternal
mood, pregnancy-related somatic symptoms (including nausea and vomiting (NVP) and carpal tunnel syndrome
(CTS) symptoms), thyroid function, and human chorionic gonadotropin (HCG) on pregnancy outcome of mother
and foetus.
Methods/design: During pregnancy, participants receive questionnaires at 12, 22 and 32 weeks of gestation.
Apart from a previous obstetric history, demographic features, distress symptoms, and pregnancy-related somatic
symptoms are assessed. Furthermore, obstetrical data of the obstetric record form and ultrasound data are collected
during pregnancy. At 12 and 30 weeks, thyroid function is assessed by blood analysis of thyroid stimulating
hormone (TSH), free thyroxine (FT4) and thyroid peroxidase antibodies (TPO-Ab), as well as HCG. Also, depression is
assessed with special focus on the two key symptoms: depressed mood and anhedonia. After childbirth, cord
blood, neonatal heel screening results and all obstetrical data with regard to start of labour, mode of delivery and
complications are collected. Moreover, mothers receive questionnaires at one week, six weeks, four, eight, and
twelve months postpartum, to investigate recovery after pregnancy and delivery, including postpartum mood
changes, emotional distress, feeding and development of the newborn.
Discussion: The key strength of this large prospective cohort study is the holistic (multifactorial) approach on
perinatal well-being combined with a longitudinal design with measurements during all trimesters of pregnancy
and the whole first year postpartum, taking into account two physiological possible markers of complaints and
symptoms throughout gestation: thyroid function and HCG. The HAPPY study is among the first to investigate
within one design physiological and psychological aspects of NVP and CTS symptoms during pregnancy. Finally,
the concept of anhedonia and depressed mood as two distinct aspects of depression and its possible relation on
obstetric outcome, breastfeeding, and postpartum well-being will be studied.
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Antenatal physical and mental well-being
Pregnancy is a period during which a woman faces a sub-
stantial number of physiological changes of the body, com-
monly together with psychological changes. These changes
often result in complaints and symptoms which are typical
to pregnancy. There are two important pregnancy-related
complaints or symptoms that are frequently observed and
regarded as consequences of substantial hormonal changes
during gestation: nausea, vomiting and symptoms of carpal
tunnel syndrome.
Nausea and vomiting during pregnancy (NVP) is a com-
mon phenomenon (50-80% of pregnancies with variable
severity [1]) and has been related to both psychological
and physiological factors, including high levels of the hor-
mone human chorionic gonadotropin (HCG) and thyroid
hormone levels. In its extreme form, NVP or ‘morning
sickness’ can manifest itself as hyperemesis gravidarum
(HG), a potentially life threatening but rare condition (0.5-
2%) which is characterised by nausea, vomiting, severe de-
hydration and weight loss resulting in hospitalisation [2].
Although most cases of HG are related to extremely
high titres of HCG (>200,000 IU/l), there have been
some reports that high levels of maternal thyroid hor-
mone (FT4) or low levels of thyrotropin (TSH) often re-
ported as thyrotoxicosis might also predispose to more
severe symptoms of NVP [3]. However, studies that in-
vestigated in one design both HCG and thyroid func-
tion, as well as psychological background features of
NVP, have not been reported.
Carpal tunnel syndrome (CTS) is common during ges-
tation and occurs because of compression of the median
nerve in the wrist in one or both hands, leading to a
tingling sensation, numbness and sometimes pain. Espe-
cially hormonal changes [4], and fluid retention [4,5]
have been suggested as contributing factors to develop-
ment of CTS in pregnancy. CTS occurs most frequently
during the third trimester of pregnancy and a majority
of women have symptoms that are severe enough to
affect hand function and sleep [6], resulting in impaired
quality of life [7,8]. Accurate data of prevalence rates are
difficult to find in the literature and vary substantially
(1-60%) [9-11]. This is mainly explained by the fact that
most women do not report the symptoms, physicians do
not ask for them and – possibly due to the conservative
attitude towards treatment during pregnancy – most
women with (substantial) CTS symptoms do not receive
electrodiagnostic examination (EDE) [12]. However, the
Boston Carpal Tunnel Questionnaire (BCTQ) [13] has
shown to be a highly reliable and sensitive self-rating
questionnaire for CTS [14,15]. Moreover, it is a user-
friendly instrument which can easily be used during preg-
nancy to assess the occurrence of CTS. An underactive
thyroid, called hypothyroidism (HT), has been long timereported to be associated with increased risk of CTS. In a
systematic review [16], the pooled odds ratio of HT pa-
tients of CTS was 1.4 indicating a 40% higher prevalence
rate of CTS in patients with HT compared to healthy con-
trols. HT might produce alterations of fluid balance and
peripheral tissue oedema resulting in nerve compression
in the carpal tunnel. A possible relation between CTS
symptoms and thyroid function during gestation has
not been reported in the literature yet. Apart from these
physiological changes, a considerable proportion of preg-
nant women experiences psychological distress, varying
from pregnancy-related worries to general symptoms of
anxiety and depression. The occurrence of distress during
pregnancy is subject to much debate: is there an increasing
number of women suffering from depression and anxiety
throughout gestation? The literature is inconclusive, mostly
because there are very few studies that repeatedly assessed
anxiety and depression. Most studies measured these
symptoms only once during pregnancy, a few studies twice,
but the systematic review of Bennett et al. [17] and the re-
view of Alder et al. [18] found no appropriate studies that
assessed symptoms of depression and anxiety during all tri-
mesters of pregnancy. Furthermore, some researchers sug-
gested symptoms of depression and anxiety to be stable
throughout pregnancy [19], while others stated that mater-
nal mood and well-being fluctuate across pregnancy [20].
With regard to depression, there is growing awareness that
the two key symptoms of depression (depressed mood and
anhedonia) are two distinct entities with possibly different
impact on health [21,22]. Depressed mood is more and
more regarded as a state, while anhedonia is regarded as
a trait factor of depression. Although this distinction
has become increasingly apparent in psycho-cardiology
[23,24] (it is especially anhedonia that has been related
to poor cardiovascular outcome rather than depressed
mood [24]), this concept has hardly been investigated in
perinatal research. As a consequence, conflicting data have
been reported on a possible relation between antenatal
mood problems and obstetric outcome. The review of
Dunkel Schetter and Tanner (2012) concluded that anx-
iety, depression and stress during pregnancy are related to
obstetric complications and adverse pregnancy outcomes,
like preterm birth and low birth weight [25]. However, a
meta-analysis in 2007 with 50 studies found no significant
evidence of an association between symptoms of anxiety
during pregnancy and adverse perinatal outcomes [26],
and a more recent meta-analysis with 35 studies found a
significant but negligible to small relationship between
stress during pregnancy and negative birth outcomes [27].
These conflicting findings are mainly to be explained by
poor methodology: regarding definition and assessment of
distress, no repeated assessments during pregnancy, and
lack of adequate sample power. Further research on de-
pression, anxiety, and stress in the different stages of
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donia) is therefore required, to investigate a possible rela-
tionship with adverse birth outcomes.
Literature also shows distress during pregnancy to be
related to increased request of epidural analgesia during
labour [28,29]. In The Netherlands, only a minority of
women asks for epidural analgesia during delivery, al-
though this number is increasing: from 6% in 2004 to 18%
in 2012 [30,31]. On the other hand, epidural analgesia has
been associated with increasing numbers of instrumental
delivery (hormonal stimulation because of weakening of
contractions, or ventouse) [32]. Studies, evaluating whether
the request of epidural analgesia is related to pregnancy-
related distress and whether the changes in distress over
time influence the request of epidural analgesia, have
hardly been published.
Concerning the long-term effects, there is growing evi-
dence that pregnancy distress might interfere with infant
development and there are studies showing long-term
effects of maternal distress throughout the childhood
and adolescence [33,34].
Maternal and foetal thyroid function during pregnancy
Adequate maternal thyroid function is extremely import-
ant during pregnancy, not only for the developing foetus
but also for optimal obstetric outcome. Up to 10% of the
women of fertile age have antibodies against thyroid per-
oxidase enzyme (TPO-Ab). The TPO-Ab are involved in
the autoimmune thyroiditis process resulting in an in-
active thyroid. These women have a 4 fold increased risk
for abortion and a 15–20 fold increased risk to develop
postpartum thyroid dysfunction [35,36]. Impaired thy-
roid function – especially high TSH referring to subclin-
ical hypothyroidism – has been related to preterm birth,
intrauterine growth restriction (IUGR), small for gesta-
tional age (SGA), and pre-eclampsia [37]. Maternal thy-
roid hormone is especially important for the developing
central nervous system (CNS) of the foetus. However, as
shown in a recent review, most studies looking at foetal
outcome and maternal thyroid function did not use intra-
uterine foetal parameters to evaluate the CNS develop-
ment, such as ultrasound data [38]. In The Netherlands,
as part of antenatal screening, every pregnant woman
receives a standardized and extremely well protocolized
ultrasound (SEO) at 20 weeks of pregnancy. During the
SEO, the foetal CNS is a special focus of interest including
assessments of ventricle size, cerebellum size, and spine
development. Also the femur length, abdominal circum-
ference, head circumference, and biparietal diameter are
measured as objective parameters of foetal growth. There
are very few data on the relation between maternal thyroid
function and SEO data. Moreover, maternal thyroid dys-
function has been related to abnormal foetal position such
as breech and problematic cephalic position, both in turnrelated to obstetrical complications [39,40]. Also, thyroid
dysfunction in general – during pregnancy and the post-
partum period – has been related to mood disorders
[41,42]. The mechanisms behind these associations are
unclear. This is partly to be explained because some asso-
ciations have been found in large epidemiological studies
that were not intended to investigate a specific role of
thyroid dysfunction on obstetric outcome and as a con-
sequence a substantial number of confounders were not
taken into account [43]. Other studies with an adequate
design suffered from poor epidemiological power (few
cases of thyroid dysfunction and obstetric complica-
tions) [44]. Large prospective studies in which thyroid
function and psycho-social characteristics have repeat-
edly been assessed during pregnancy are scarce. More-
over, adding a biological variable (thyroid function) to a
model with predominantly psychological variables (ma-
ternal depression and anxiety during pregnancy), may
elucidate on the multifactorial origin of impaired infant
development as has been published before by our re-
search group [45,46].
The early postpartum period
Neonatal thyroid function
After birth, there is a neonatal TSH surge to stimulate
neonatal thyroid function in order to start brown fat pro-
duction for thermogenesis. The umbilical blood vessels
are thought to accurately reflect neonatal thyroid function
before the TSH surge starts and assessment of thyroid
function in the umbilical cord will reflect maternal thyroid
hormone function during the last trimester [47,48]. As in
most Western countries, in The Netherlands, there is a
nationwide congenital screening program of neonatal
thyroid function between three to five days postpartum.
Until now, little is known about the relation between
maternal thyroid hormone levels in pregnancy, umbil-
ical cord levels, and neonatal heel screening results.
Within the HAPPY study, pairs of maternal and neo-
natal thyroid data will be sampled to investigate whether
poor maternal thyroid function has neonatal thyroid
function consequences. From previous research in the
same area it is known that because of logistic difficulties
(home delivery, referral during labour from home to
hospital, delivery in different hospitals) in about 70% of
the participating women umbilical cord blood will be
obtained [47].
Maternal well-being and infant development during the
postpartum period
Up until now, it is unknown how long the period lasts that
a woman normally needs to recover from pregnancy and
delivery. Similar to pregnancy, there is hardly any insight
into complaints and symptoms that occur during the post-
partum recovery period: what are typical complaints and
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it end, is it related to feeding sessions at night, or to com-
plicated delivery? As a consequence, many physiological
signs and symptoms which seem to be typical for the
postpartum period (cognitive and sleeping problems)
are incorrectly related to postpartum depression, which
is generally regarded as a stigmatizing condition. Postpar-
tum mood disorders mostly refer to postpartum blues (oc-
curring in 40% to 80% of the women preferentially during
the first postpartum week) and postpartum depression
with prevalence between 13-19% [49]. The negative effect
of (especially ‘chronic’) maternal depression on the de-
veloping child has extensively been described [50-53].
Depressed mothers may become apathetic, emotionally
withdrawn, and unresponsive to their offspring [52],
while the first months of the newborn’s life are the ‘sensi-
tive period’ for the mother-child bonding [53]. Maternal
postpartum depression is harmful to the development of
the newborn, whose early socialization, cognitive devel-
opment, and speech acquisition are largely in mother’s
hands [52].
However, research that assesses maternal distress on a
regular basis during pregnancy and during a substantial
period of time during the postpartum period is scarce.
Furthermore, it is interesting to investigate possible dif-
ferences between the impact of distress at different time
points during gestation (first versus third trimester) on
infant development.
Breastfeeding
The WHO and UNICEF have rather strict criteria defin-
ing optimal patterns of breastfeeding: 1) early initiation
of breastfeeding within one hour of birth; 2) exclusive
breastfeeding for the first six months of life; and 3) the
introduction of nutritionally-adequate and safe comple-
mentary (solid) foods at six months together with contin-
ued breastfeeding up to two years of age or beyond [54].
However, many infants and children do not receive opti-
mal feeding. For example, only about 38% of infants
aged up to six months worldwide are exclusively breast-
fed [54]. In The Netherlands, about 75% of the women
start breastfeeding after childbirth but almost half of
them has stopped within the first three months postpar-
tum and less than 25% still breastfeed at six months
postpartum [55,56]. In Norway and Sweden, more than
95% of the women start breastfeeding and 67-80% of
these Scandinavian women still breastfeed at six months
postpartum [57,58]. Determinants that predict start and
continuation of breastfeeding are of multifactorial origin
including educational level, socioeconomic status, marital
status, partner involvement, and maternal distress during
gestation and postpartum [59]. Also, facilities at work to
breastfeed [60] and the perceived milk supply [61] influ-
ence the duration of breastfeeding. When women aredepressed during pregnancy, they are less likely to initiate
or to maintain breastfeeding [62,63]. However, the rela-
tion between postpartum depression and breastfeeding
remains equivocal [63]. There is still the dispute whether
women who discontinue breastfeeding are at increased
risk for postpartum depression or vice versa: are women
with postpartum depression at risk for poor breastfeeding
‘behaviour’? It is important to detect women who experi-
ence difficulties with the challenges of breastfeeding (e.g.
low milk production, infant weight loss while being exclu-
sively breastfed, etc.) despite their willingness and con-
tinuous efforts to try to breastfeed their infants. Antenatal
intervention techniques (including involvement of the
partner in decision making) can increase the likelihood to
breastfeed [64].
Moreover, the effect of epidural analgesia during labour
on the start and continuation of breastfeeding during the
early postpartum week is poorly understood. A recent
study showed a 26% increased risk of not initiating breast-
feeding after epidural anaesthesia in primiparous women
who delivered vaginally [65]. Similarly, it has long been
noticed that oxytocin also has an impact on the CNS, and
oxytocin and vasopressin are hypothesized to integrate
social information into attachment processes. There is
growing evidence that oxytocin might be useful as an
antipsychotic drug in the future. These days, synthetic
oxytocin is the most common medical intervention in
childbirth, despite the great variety of plausible side effects
[66]. There are theoretical reasons to test whether the in-
creasing incidence of breastfeeding difficulties and the
earlier than desired cessation of breastfeeding are related
to the use of synthetic oxytocin during labour [66]. A re-
cent study from Spain showed an odds ratio for bottle-
feeding of 1.45 (95% CI 1.29-1.64) and of 2.29 (95% CI
1.41-3.74) for withdrawal of breastfeeding at three months
in those women who received oxytocin during labour
[66]. However, because oxytocin is often given in case of
weakness of contractions which occurs frequently in
women who ask for epidural anaesthesia, this request be-
ing partly to be explained by psychological characteristics,
it is obvious that investigating a possible relation between
oxytocin use and breastfeeding patterns needs a multifac-
torial design.
Study objectives and hypotheses
The HAPPY study (Holistic Approach to Pregnancy and
the first Postpartum Year) contains several aims with re-
gard to both pregnancy and the postpartum period.
The primary aim of HAPPY concerning pregnancy is
to measure the prevalence and changes in pregnancy-
related complaints and symptoms over time, with special
focus on NVP and CTS. Both a psychological and a
physiological model will be tested to explain the variance
of (severe) NVP and CTS symptoms (Figure 1).
Figure 1 Multifactorial model with hypothesized associations between physiological and psychological factors during pregnancy.
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depression) is assessed during different trimesters. Sec-
ondly, the changes in thyroid function are measured over
time during pregnancy and we will investigate a possible
independent effect of thyroid dysfunction on foetal devel-
opment as assessed by a standardized ultrasound protocol
at 18–22 weeks gestation. Moreover, a possible independ-
ent effect of thyroid dysfunction on maternal mood will
be investigated as well as on obstetric outcome including
abnormal foetal position at term, the prevalence of pre-
term birth (<37 weeks of gestation) and its possible
causes such as preterm premature rupture of mem-
branes (PPROM), the occurrence of pre-eclampsia and
other obstetric complications.
Apart from collecting observational data, the following
hypotheses will be tested:
 Both physiological (HCG and thyroid hormone) and
psychological parameters predict the occurrence of
(severe) NVP symptoms
 Women with suboptimal thyroid function (reflected
by high TSH levels) are at particular risk of developing
(severe) CTS symptoms during the last trimester
 Women with high TSH and/or high titres of
TPO-Ab during early gestation are at particular risk
for poor foetal neurologic development assessed by
ultrasound at 20 weeks gestation
 Women with subclinical hypothyroidism are at risk
for developing pre-eclampsia, IUGR, SGA and
preterm birth
 Chronic depression during gestation is predominantly
to be explained by anhedonic symptoms at baseline
(first trimester) rather than depressed mood
 It is the anhedonic mood rather the depressed mood
of the concept of depression that interferes with
poor obstetric outcome Distressed women in particular ask for epidural
analgesia at delivery.
With regard to the postpartum period, the primary
aim is to investigate the effect of chronic depression dur-
ing pregnancy on postpartum recovery. Secondary out-
come is the impact of thyroid autoimmune disease on
postpartum depression. Tertiary outcome is the relation
between psychological determinants and initiating and
continuation of breastfeeding. The following hypotheses
have been developed regarding the postpartum period:
 Women with an auto-immune compromised thyroid
function (as reflected by the presence of elevated
titres of TPO-Ab assessed during pregnancy) are at
risk for developing postpartum depression
 Within the concept of depression, it is anhedonia
rather than depressed mood assessed during
pregnancy that predicts the occurrence of (chronic)
postpartum depression
 Women with high levels of distress during
pregnancy and postpartum are at risk for poor
breastfeeding figures (both starting and
continuation)
 Women who receive epidural analgesia during
labour are at risk for poor breastfeeding figures
during the first postpartum week.
Methods/design
Design and setting
The HAPPY study is a population-based prospective lon-
gitudinal cohort study from early pregnancy up to the
end of the first post-partum year. The HAPPY study is
conducted in South-East Brabant (southern part of The
Netherlands), in the Eindhoven area. South-East Brabant
is defined as semi-rural and about 7,000 babies were
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practices (consisting of 55 midwives) consented to par-
ticipate in the recruitment of participants. Furthermore,
the two obstetric departments of two large hospitals in
the area collaborate. The care providers of the obstetric
departments collect umbilical cord blood after delivery
and provide the fully completed obstetric record forms
for data analysis after written informed consent of the
participants. The Primary Care laboratory of Eindhoven
(Diagnostiek voor U) is responsible for collection of the
blood samples and the ultrasounds. The Laboratory of
clinical chemistry and haematology of the Máxima Med-
ical Centre Veldhoven is responsible for analysis of TSH,
FT4, TPO-Ab and HCG and storage of the blood samples.
Recruitment
Dutch-speaking Caucasian women (or third generation
women of other ethnic groups) who have their first pre-
natal visit between January 2013 and September 2014
are eligible to participate in the study from the early
beginning of their pregnancy. Exclusion criteria in this
study are: gemelli pregnancy (or higher order pregnan-
cies), endocrine disorder, use of thyroid medication, se-
vere psychiatric disease (schizophrenia, borderline, or
bipolar disorder), HIV, drug or alcohol addiction prob-
lems, or any other disease resulting in treatment with
drugs that are potentially adverse for the foetus and need
careful follow-up during pregnancy. Eligible pregnant
women (and their partner) receive written and oral infor-
mation about the study at their first prenatal visit. Recruit-
ment takes place by the midwives of 17 primary care
community midwife practices in the area of South-East
Brabant, from January 2013 until September 2014.
The Dutch obstetric care system is organised in pri-
mary care - represented by independent midwives pro-
viding care to women with low-risk pregnancies - and
secondary care, represented by hospital midwives and
gynaecologists who are responsible for high-risk pregnan-
cies. Management of 84% of all pregnant women starts in
midwifery practices [31]. The other 16% are high-risk. The
high-risk population consists of women with gemelli preg-
nancy or with chronic diseases such as diabetes, thyroid
dysfunction, hypertension, or psychiatric disorders; all
exclusion criteria for participation. As 84% [31] of all preg-
nant women will have at least one prenatal visit in a pri-
mary care midwifery practice (usually a first antenatal
control between six to ten weeks of gestation), recruit-
ment takes place by the primary care community mid-
wives. If women decide to participate, written informed
consent is obtained. During regular blood assessments
(10–12 weeks and 26–30 weeks of gestation), an add-
itional tube of blood is withdrawn for thyroid function
and HCG analysis. This means that no additional inter-
ventions are needed. Written informed consent includesparticipation in the study and inclusion of all obstetric
data from the medical record form of the community
midwife and obstetrician (including ultrasound data), a
detailed delivery description and neonatal condition, and
data of newborn screening (heel prick test).
The HAPPY study is approved by the Ethical Board of
Tilburg University (with special attention to the type of
questionnaires that are used) and has been evaluated by
the Medical Ethical Committee of the Máxima Medical
Centre Veldhoven. Because all additional blood samples
were obtained during regular blood assessments as part
of regular obstetric care, the board confirmed that no
additional approval of a medical committee was needed.Sample size calculation
The total amount of pregnancies in the area of the 17
community midwife practices is about 5,000 per year.
With 10-15% non-Caucasian, 10-15% early abortion rate
and 1.7% gemelli pregnancies, approximately 3,700
pregnant women will be eligible annually. Based on pre-
vious pregnancy-related research experiences of the last
20 years in this area, the response rate is expected to be
high (70%) especially when no additional blood tests or
interventions have to be performed. This will result in
about 2,600 inclusions annually. During pregnancy, the
rate of women moving outside the area is in general low
which means that a number of 2,500 women are ex-
pected to finish the study protocol until delivery. After a
pilot period of three months followed by a running-in
period of three months, it is estimated that all midwife
practices will collaborate within six months. Therefore,
the period of recruitment will take about 18 months to
include 2,600 women.
Because different types of events with different preva-
lence rates might interfere with the sample size needed
for appropriate statistics, the number of 2,500 women is
estimated to meet the standard epidemiological criteria.
With 2,500 participants, the following numbers of ab-
normal events are estimated to be found: 108 women
with a foetus in breech position (4.3%) [31], 185 preterm
births (7.4%) [31], 450 women (18%) [67] will develop
depression during pregnancy and 325–475 women (13-
19%) will develop postpartum depression [49,67] during
the first postpartum year. According to thyroid func-
tion, we will find 200 (8%) women with elevated titres of
TPO-Ab and 100 with TSH > 2.5 IU/l [36]. These num-
bers will allow statistical analysis with sufficient power.
According to Pocock [68], with an expected prevalence
rate of 4-10% (breech, preterm birth, TPO antibodies,
TSH > 2.5), a significance level of 5% and a power of
80%, 1,500-2,140 women need to be included (depend-
ing on the expected prevalence rate). In order to antici-
pate on (low) drop out, 2,600 women will be included.
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Questionnaire assessments during pregnancy are planned
in each trimesters of pregnancy (T1-T3, Figure 2). Partici-
pants receive the questionnaires by postal mail or internet
according to the woman’s personal choice. If a woman
does not respond within one week, a researcher of the
study team (CB), will call her to inform whether she re-
ceived the questionnaire and check her email or postal
address if this was not the case. After checking the contact
information, the women will receive a reminder email (or
reminder call). If a woman does not respond – despite
having received a written informed consent – she is
regarded as lost to follow-up. If obstetric data that are col-
lected by questionnaires during pregnancy are missing
(parity, previous abortion e.g.) these data will be collected
from the parturition record form which contains all rele-
vant obstetric data.
Apart from a previous obstetric history, the question-
naires include demographic features, assessment of
distress symptoms and somatic symptoms which are
frequently mentioned during physiological gestation.
During pregnancy, the obstetrical data from the obstet-
ric record form and ultrasound data (at 12 and 20 weeks
of gestation) are collected.
Furthermore, at standardized blood assessment around
10–12 weeks and 26–30 weeks of gestation an additional
tube of blood is withdrawn for thyroid function assess-
ment and HCG analysis.
If collection of an additional tube of blood fails, these
data (thyroid parameters and HCG) will be regarded as
missing, because the study protocol does not allow to
perform an additional venipuncture.
After childbirth, all obstetrical data with regard to start
of labour, mode of delivery and complications are col-
lected. Moreover, cord blood is collected after cutting of
the umbilical cord, to be used for neonatal thyroid func-
tion assessment, which accurately represents foetal thyroid
function. Since the additional tube of blood is drawn dur-
ing the regular blood assessment (which already needs a
venipuncture), and the umbilical cord and the placenta
normally are thrown away for destruction after birth, it
can be stated that there are no additional interventionsFigure 2 Timetable of assessments during pregnancy.performed to either mother or the newborn within the
HAPPY study.
In the postpartum period, questionnaire assessments
have been planned at one and six weeks and at 4, 8, and
12 months postpartum (T4-T8, Figure 3).
Materials/measures
Obstetric history, perinatal measures and obstetrical
outcomes
The obstetric record form which is standardized in our
country is used to collect all relevant data of pregnancy
and delivery from the community midwife and/or the
obstetrician. Obstetric data like blood pressures during
pregnancy, gestational age at birth, usage of anaesthesia,
mode of delivery, duration of labour, complications, and
birth weight are carefully assessed by the care providers.
The standardized 20 weeks ultrasound (SEO)
The following data – assessed during the SEO – are
used in HAPPY: the biparietal diameter, ventricle size,
cerebellum size, and femur length. Data of ultrasounds
performed at other time points during gestation are also
collected.
Blood analysis of thyroid function and HCG
TSH, FT4, TPO-Ab, and HCG are measured in Li-
heparin plasma using electrochemoluminescence assays
(Cobas® e 601, Roche Diagnostics, Mannheim Germany).
The non-pregnant reference range of TSH is 0.4-4.0 mU/L,
of FT4 10.0-24.0 pmol/L, and of TPO-Ab < 35 kU/L. The
reference ranges of TSH and FT4 at the first and third tri-
mester will be defined in TPO-Ab negative women using
the 2.5th and 97.5th percentiles as lower and upper limit of
normal thyroid function.
Questionnaires
At eight time points during the period between 12 weeks
gestation and 12 months postpartum, the participants
receive several questionnaires as shown in Table 1.
To measure pregnancy-related emotional distress, the
16-item Tilburg Pregnancy Distress Scale (TPDS) [69]
with subscales ‘negative affect’ and ‘partner involvement’
Figure 3 Timetable of assessments during the first postpartum year.
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http://www.biomedcentral.com/1471-2393/14/312is assessed at each trimester of pregnancy. The TPDS
has been validated among Dutch pregnant women and
showed good internal consistency overall (Cronbach’s
alpha = 0.78), as well as for each subscale (negative affect
(TPDS-NA), 11 items, alpha = 0.80; partner involvement
(TPDS-PI), 5 items, alpha = 0.80) [69].
Symptoms of depression during pregnancy are mea-
sured with the 10-item Edinburgh Depression Scale
(EDS), validated in Dutch postpartum women [70,71] as
well as pregnant women [72]. The EDS is a reliable in-
strument for screening depression in each of the three
trimesters of pregnancy. The reliability values of the
EDS indicated by Cronbach's alpha-coefficient per tri-
mester are respectively 0.82, 0.83, and 0.84 [72]. The
EDS total score ranges from 0 to 30, with higher scores
indicating more depressive symptoms. Trimester-specific
cut-off points were determined, lower than the commonly
applied cut-off in the postpartum period. A cut-off value
of 11 in the first trimester and of 10 in the second and
third trimesters gives the most adequate combination of
sensitivity, specificity, and positive predictive value [72].
The EDS has repeatedly been shown to consist of three
subscales: anhedonia, anxiety and depression, with an-
hedonia and depression assessing different concepts of
depression [73]. However, the anhedonia subscale only
consists of two items. Therefore, within the HAPPY
study, the EDS has been extended with several anhedo-
nia items depicted from the Dutch validated version of
the MASQ (Mood and Anxiety Symptoms Question-
naire, originally developed by Watson and Clark in 1991
[74,75]). Psychometric properties of this extended 14-
item EDS-version will be tested in a subsample.
During the postpartum period, the Edinburgh Postna-
tal Depression Scale (EPDS) is used to assess depressive
symptoms at one and six weeks postpartum and at 3, 6Table 1 Time points of assessments during pregnancy and th
Concept Instrument Time points during pregnancy (T
T1 T2
12wk 22wk 3
Pregnancy distress TPDS X X
Depression E(P)DS X X
Anxiety GAD-7 X X
NVP PUQE X
CTS BCTQ
BCTQ: Boston Carpal Tunnel Questionnaire; CTS: Carpal Tunnel Syndrome; E(P)DS: E
scale; NVP: nausea and vomiting during pregnancy; PUQE: Pregnancy-Unique Quanand 12 months postpartum. The 10-item EPDS has been
validated among postpartum women in The Netherlands
and revealed appropriate psychometric characteristics
with a Cronbach’s alpha of 0.87 [70,71]. The total score
ranges from 0 to 30, with higher scores indicating more
depressive symptoms. A cut-off value of 9 will be used
to detect a possible postpartum depression [76].
The Generalized Anxiety Disorder scale (GAD-7) is a
valid and reliable (Cronbach’s alpha = 0.89) device for
screening generalized anxiety disorder and for assessing
its severity [77,78]. The GAD-7 consists of seven items
with a four-point Likert scale (0 = ‘not at all’ to 3 = ‘nearly
every day’). The total score ranges from 0 to 21, with
higher scores representing higher levels of anxiety symp-
toms [77]. Cut-off points of 5, 10, and 15 are associated
with respectively mild, moderate, and severe levels of
anxiety [78].
To assess the severity of NVP (or ‘morning sickness’) in
the early phase of pregnancy, we use the first trimester
Pregnancy-Unique Quantification of Emesis (PUQE) scale
[2]. The assessment is based on three physical symptoms
over the first trimester: nausea, vomiting, and retching.
The PUQE, which consists of three quantification items
with five answer categories, appears to be a reliable instru-
ment to determine severity of nausea and vomiting during
pregnancy [2]. Within the HAPPY study, the Dutch ver-
sion of the PUQE is assumed to be validated.
To examine CTS, the question: “Did you suffer any of
the following symptoms during pregnancy: pain, tingling
sensations, or numbness in hands or wrists?” is used in-
cluding the three key symptoms of CTS. Subsequently,
the Boston Carpal Tunnel Questionnaire (BCTQ) is a
disease-specific CTS questionnaire that consists of two
subscales: the symptom severity scale (11 items) and the
functional status scale (8 items). It has been validated ine first postpartum year
1-T3) Time points in the first postpartum year (T4-T8)
T3 T4 T5 T6 T7 T8
2wk 1 wk 6 wk 4 mnth 8 mnth 12 mnth
X
X X X X X X
X X X X X X
X X X X X X
dinburgh (Postnatal) Depression Scale; GAD-7: Generalized Anxiety Disorder
tification of Emesis; TPDS: Tilburg Pregnancy Distress Scale.
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ties [79]. The BCTQ is assessed at 32 weeks of gestation
and retrospectively at one week postpartum to evaluate
CTS symptoms during the last eight weeks of pregnancy.
Moreover, in order to evaluate the course of symptoms
after childbearing it is assessed at 6 weeks, and 4, 8 and
12 months postpartum.
Furthermore, women are asked whether a negative
event did occur during the first trimester of pregnancy
or during the period between the previous and next as-
sessment until 12 months postpartum.
Statistical analyses
Statistical analyses will be performed using SPSS 20.0
(Statistical Package for Social Sciences version 20, IBM,
Chicago, Illinois, USA). The confirmatory factor analysis
will be done using AMOS (version 18, IBM, Chicago,
Illinois, USA).
First, we will test for normality and the computation
of descriptive statistics. Data will be presented as mean
scores ± SD for continuous data and as percentages for
categorical data. At a univariate level, differences in mean
scores on questionnaires between subgroups (e.g. with
and without thyroid dysfunction, preterm birth, or major
depression) will be analysed using t-tests (for parametric
data) and Mann–Whitney-U tests (for non-parametric
data). Significance will be tested two-sided at a signifi-
cance level of 0.05. Relations between continuous variables
will be calculated using Pearson or Spearman correlations.
In order to test the psychometric properties of (partially)
new scales (extended EDS, PUQE e.g.), factor analysis will
be performed as well as reliability analysis in subsamples.
For this purpose, samples of women will be randomly se-
lected by the computer. One sample will be used for ex-
plorative factor and reliability analysis (Cronbach’s alpha).
A principal component analysis with oblimin rotation and
a scree test will be used to select factors for retention.
Factor loadings above 0.40 are considered important. The
minimum value of the Kaiser-Meyer-Olkin (KMO) index
for a good factor analysis is suggested to be ≥ 0.60 [80]
and the Bartlett’s test for sphericity value reaches signifi-
cance at 0.05 level. Internal consistency analyses will be
conducted using Cronbach’s alpha for the total scale and
possible subscales derived from factor analysis. Cronbach’s
alpha reliability statistic of ≥ 0.70 is considered as the
minimum acceptable criterion of instrument internal reli-
ability [81]. In a similar second sample confirmative factor
analysis (CFA with AMOS, IBM) will be used to test sta-
bility of the factor structures as found in the first sam-
ple. The comparative fit index (CFI), normed fit index
(NFI), and the root mean square error of approximation
(RMSEA) are generally considered good parameters to
evaluate model fit. Adequate model fit can be assumed
with a CFI ≥ 0.80, NFI ≥ 0.80, and RMSEA ≤ 0.05 forgood and ≤ 0.08 for adequate fit [82,83]. Similar proce-
dures will be used for other new questionnaires with the
assumption that four to ten participants per item with a
minimum of 100 participants are needed for adequate
analysis [81,84].
At a multivariate level, different techniques will be used.
In order to evaluate possible causality between different
variables path analysis will be performed using structural
equation modelling (SEM). For continuous dependent var-
iables (for example PUQE scores or depression scores on
the EDS) linear regression models will be used. Stepwise
regression analysis will be performed, starting with the in-
dependent variable in a first model. Subsequently, block
entry with different confounders will be used to calculate
the total explained variance (R2) and Cohen’s effect size.
For these analyses, the EDS scores will be used to define
depression as well as the subscales depression and anhe-
donia. Differences in predicting obstetric outcome will be
evaluated for these subscales. With dichotomous variables
(preterm birth yes/no e.g.) as dependent variable, single
and multiple logistic regression analyses (O.R., 95% CI)
will be performed entering the independent variable as
well as several confounders into the model.
Regarding CTS, a multiple logistic regression analysis
will be performed, with the presence of self-reported CTS
(based on the question: “Did you suffer any of the follow-
ing symptoms during pregnancy: pain, tingling sensations,
or numbness in hands or wrists?”) as the dependent vari-
able and fluid retention during pregnancy as independent
variable, adjusted for age, parity, BMI, and depression.
Furthermore, a multiple linear regression analysis will
be performed, with BCTQ score (indicating CTS sever-
ity) as dependent variable and fluid retention during
pregnancy as independent variable, adjusted for age,
parity, BMI, and depression.
Linear mixed effect models will be used to determine
the effect of scores on the EDS and the GAD-7 during
different trimesters on the request for epidural anaesthesia
during labour, obstetric complications, the occurrence of
postpartum depression, and the start and continuation of
breastfeeding. Linear mixed effect models are able to ad-
just for missing values and are therefore used to avoid loss
of information [85].
For answering the various research questions, different
models will be used containing different dependent and
independent variables. Confounding variables will be
entered into the model according to the literature. The
variables age, parity and educational level will be used as
confounders in all the models. For example: in examin-
ing determinants of start/continuation of breastfeeding
during the early postpartum period, obstetric outcome
will be entered into the regression as a confounder, while
for assessing determinants of CTS, the variable BMI will
be included as confounder.
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Within the HAPPY study, we aim to evaluate the relation-
ships between several physiological and psychological fac-
tors and antenatal and postpartum maternal and infant
well-being. The key strength of this large prospective co-
hort study is the holistic (multifactorial) approach on peri-
natal well-being combined with a longitudinal design with
measurements during all trimesters of pregnancy and the
whole first year postpartum. The HAPPY study is unique
in several aspects.
First, within one design, a psycho-physiological model
to explain NVP will be tested with special attention to
HCG and thyroid function. This multifactorial approach
to investigate NVP has not yet been reported in litera-
ture. Secondly, the prevalence of CTS is assessed using a
standardized and validated questionnaire and a possible
relation between CTS symptoms and thyroid function
during pregnancy will be tested, which has never been
reported before. Third, suboptimal maternal thyroid
function has repeatedly been associated with poor de-
velopment of the foetal CNS. However, combining ma-
ternal thyroid function with the objective parameters of
development of the CNS assessed by ultrasound at
20 weeks gestation has hardly been described. Fourth,
within the abundant literature on perinatal depression,
there are very few papers looking at the concept of an-
hedonia and depressed mood, the two key symptoms of
depression. Fifth, because The Netherlands have rela-
tively few women asking for epidural anaesthesia during
labour (a risk factor for increased instrumental deliv-
ery), it is possible to look at psychological determinants
predicting a request of analgesia. Finally, the attitude to-
wards initiating and continuation of breastfeeding are
assessed, taking into account demographic and psycho-
logical characteristics that have repeatedly been assessed
during gestation.
Another strength of the study is the large sample size
(2,500 participants) which will enable to look at possible
relations between psychological and physiological deter-
minants and obstetric complications but which are rela-
tively rare (preterm birth, pre-eclampsia, intrauterine
growth restriction). Moreover, the sample size will enable
us to validate several questionnaires with explorative and
confirmative factor analyses and to use the validated ver-
sions in subsamples of HAPPY that are large enough to
answer research questions.
The feasibility of HAPPY is guaranteed by the high
experience of the perinatal research group of Tilburg
University which has an experience of over 20 years of
research in this field. During this period several co-
horts have been formed showing an overall and stable
recruitment rate of over 70% after inviting women
through their midwife to participate into pregnancy re-
search [69,72,86].Abbreviations
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